Back to Journals » Biologics: Targets and Therapy » Volume 9

Letter

Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib

       
Total article views   HTML views PDF downloads Totals
11,078 Dovepress* 10,632+ 1,768 12,400
PubMed Central* 446 156 602
Totals 11,078 1,924 13,002
*Since 19 February 2015
+Since July 2016

View citations on PubMed Central and Google Scholar